Price $37.15 |
Market Cap
7.4B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.22
|
P/S
5.72
|
Dividend %
-
|
|
P/CF
15.0
|
P/FCF
60.1
|
Op. Cash Flow
274.8K
|
FCF
0.6
|
|
Op. Margin
12.20%
|
Net Margin
3.80%
|
ROE
2.20%
|
ROI
0.40%
|
|
ROA
1.10%
|
EPS Growth
-33.80%
|
Current Ratio
5.1
|
Debt/Equity
69.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $26.86 | - | - | 7.68B | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.06 | - | - | 44.2M | Strong Buy |
| Bovie Medical Corporation (BVX) | $3.80 | - | - | 128.9M | Strong Buy |
| Hologic, Inc. (HOLX) | $40.43 | - | - | 10.34B | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.44 | - | - | 27.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
